Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Clinical trial NCT00693485 · COMPLETED

Trial details

NCT number: NCT00693485
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glaucoma, Open-Angle

Start date: 2008-09-01
Primary completion: 2011-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.